What it's for (Indications)
- Cyproheptadine, the active pharmaceutical ingredient often associated with appetite stimulation in products like Trimetabol, is primarily indicated for the symptomatic relief of various allergic conditions.
- These include seasonal and perennial allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, urticaria, angioedema, and dermatographism.
- Its potent antihistaminic and antiserotonergic effects are foundational to its therapeutic profile.
- Additionally, due to its effect on serotonin receptors in the hypothalamus, cyproheptadine is frequently utilized off-label as an appetite stimulant.
- This particular use is common in patients experiencing appetite loss or difficulty gaining weight, such as children with failure to thrive, individuals with chronic debilitating illnesses, or those undergoing treatments that suppress appetite.
- The precise mechanism for appetite stimulation is believed to involve antagonism of specific serotonin receptors in the brain's appetite regulation centers, leading to increased caloric intake.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The dosage of cyproheptadine requires careful titration and is highly dependent on the specific indication, patient's age, body weight, and individual response to treatment, always under the guidance of a healthcare professional. For adults prescribed for allergic conditions, a typical starting dose is 4 mg taken orally three times daily. The maintenance dose generally ranges from 4 mg to 20 mg per day, with a strict maximum daily dose of 32 mg. When used for its appetite stimulant properties, which is a common application for products like Trimetabol, doses typically range from 2 mg to 8 mg administered orally two to three times per day. Pediatric dosing is usually calculated based on body weight, often commencing at approximately 0.25 mg/kg/day, divided into two or three equal doses. Liquid formulations, such as syrups (e.g., 2 mg/5 mL), are frequently employed to facilitate accurate dosing in pediatric populations. |
Safety & Warnings
Common Side Effects
- The most frequently encountered and prominent side effect of cyproheptadine is marked central nervous system depression, manifesting as significant drowsiness, sedation, and dizziness.
- These effects are particularly pronounced during the initial phase of treatment.
- Due to its anticholinergic properties, other common adverse reactions include xerostomia (dry mouth), blurred vision, constipation, urinary retention, and thickening of bronchial secretions.
- Less common but potentially serious side effects can involve the central nervous system, leading to paradoxical excitation (especially in pediatric patients), disorientation, ataxia, and hypotension.
- Hematologic abnormalities, such as hemolytic anemia, thrombocytopenia, and agranulocytosis, are rare but severe complications.
- Patients are strongly cautioned against engaging in activities requiring mental alertness, such as driving or operating heavy machinery, until the full extent of these effects is known.
Serious Warnings
- Black Box Warning: Although cyproheptadine does not carry a formal FDA-mandated Black Box Warning, it is imperative to highlight several serious safety concerns that warrant prominent attention, functioning as an equivalent to a 'Serious Warnings' section. A critical warning pertains to the profound and debilitating sedative effects, including severe drowsiness and dizziness, which can significantly impair mental alertness and physical coordination required for tasks such as driving, operating heavy machinery, or any activity requiring precision. This risk is substantially amplified when cyproheptadine is used concurrently with alcohol or other central nervous system depressants (e.g., opioids, benzodiazepines, sedatives), potentially leading to severe respiratory depression and profound impairment. Furthermore, there is a documented risk of paradoxical excitation, hallucinations, and convulsions, particularly observed in pediatric patients, which can be life-threatening if not managed promptly. Due to its potent anticholinergic properties, healthcare providers must exercise extreme caution or completely avoid its use in elderly patients and those with pre-existing conditions such as narrow-angle glaucoma, urinary retention secondary to prostatic hypertrophy, or pyloroduodenal obstruction, as it can critically worsen these conditions. Comprehensive patient counseling regarding these significant risks is essential prior to initiating treatment.
- Cyproheptadine must be administered with extreme caution, or altogether avoided, in patients with pre-existing medical conditions that may be exacerbated by its pharmacological effects.
- These include individuals with narrow-angle glaucoma, benign prostatic hypertrophy or other forms of bladder neck obstruction, and pyloroduodenal obstruction, as its potent anticholinergic properties can worsen these conditions.
- Elderly and debilitated patients are particularly susceptible to the sedative and anticholinergic effects.
- Due to its propensity to cause significant drowsiness, patients must be explicitly warned about impaired cognitive and motor skills, making tasks such as driving or operating heavy machinery hazardous.
- Concurrent consumption of alcohol or other central nervous system depressants (e.
- g.
- , sedatives, hypnotics, tranquilizers, anxiolytics) can potentiate the sedative effects of cyproheptadine, leading to profound CNS depression and increased risk of respiratory compromise.
- Pediatric patients, especially infants and young children, are more prone to paradoxical excitation, hallucinations, seizures, and even death when administered antihistamines, particularly in overdose situations.
- Therefore, careful monitoring and adherence to prescribed dosages are crucial.
How it Works (Mechanism of Action)
Cyproheptadine exerts its primary therapeutic effects through a multifaceted pharmacological profile. It functions as a potent antagonist at histamine H1 receptors, thereby effectively blocking the actions of histamine, which is a key mediator in various allergic reactions responsible for symptoms such as pruritus (itching), sneezing, and rhinorrhea. In addition to its antihistaminic properties, cyproheptadine also acts as a robust antagonist at serotonin 5-HT2A and 5-HT2C receptors within the central nervous system, particularly in areas like the hypothalamus. This antiserotonergic action is widely believed to be the principal mechanism by which cyproheptadine stimulates appetite and promotes weight gain, by interfering with serotonin's role in satiety signaling. Furthermore, cyproheptadine possesses notable anticholinergic activity, which contributes to some of its adverse effects, including dry mouth, blurred vision, and urinary retention, and some alpha-adrenergic blocking activity.
Commercial Brands (Alternatives)
No other brands found for this formula.